Skip to main content

Table 5 All grade 3 and 4 adverse events (n = 44)

From: Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

Adverse event Grade 3 Grade 4   
  N % N %
Anemia 5 11.4 1 2.3
Neutropenia 2 4.5 5 11.4
Thrombocytopenia 4 9.1 6 13.6
Tumor lysis syndrome 2 4.5 1 2.3
Interstitial pneumonitis 1 2.3 0 0
Ileus 1 2.3 0 0
Herpes zoster infections 1 2.3 0 0